These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 1908489

  • 1. Studies on the influence of gonadotrophin levels in the early follicular phase on the ovarian response to stimulation.
    Forman RG, Demouzon J, Feinstein MC, Testart J, Frydman R.
    Hum Reprod; 1991 Jan; 6(1):113-7. PubMed ID: 1908489
    [Abstract] [Full Text] [Related]

  • 2. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH, Garzo G, Morris S, Stuenkel C, Ulmann A, Yen SS.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [Abstract] [Full Text] [Related]

  • 3. Human urinary follicle-stimulating hormone and human menopausal gonadotropin in induction of multiple follicle growth and ovulation.
    Venturoli S, Orsini LF, Paradisi R, Fabbri R, Porcu E, Magrini O, Flamigni C.
    Fertil Steril; 1986 Jan; 45(1):30-5. PubMed ID: 3080344
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Monitoring of ovulation induction.
    Wu CH.
    Fertil Steril; 1978 Dec; 30(6):617-30. PubMed ID: 729822
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT, Ohlinger R.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):87-92. PubMed ID: 16377065
    [Abstract] [Full Text] [Related]

  • 7. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
    Yuen BH, Sy L, Cannon W.
    Am J Obstet Gynecol; 1981 Jul 15; 140(6):629-35. PubMed ID: 6167169
    [Abstract] [Full Text] [Related]

  • 8. Rapid inhibitory effects of an LHRH agonist implant on the oestrogen-induced LH surge and the induction of a defective luteal phase after an agonist-induced ovulation in the macaque.
    Fraser HM, Lunn SF.
    Hum Reprod; 1989 Jul 15; 4(5):506-12. PubMed ID: 2507574
    [Abstract] [Full Text] [Related]

  • 9. Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease.
    van Weissenbruch MM, Schoemaker HC, Drexhage HA, Schoemaker J.
    Hum Reprod; 1993 Jun 15; 8(6):813-21. PubMed ID: 8345068
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of low dose purified FSH in ovulation induction following pituitary desensitization in polycystic ovarian syndrome.
    Buckler HM, Critchley HO, Cantrill JA, Shalet SM, Anderson DC, Robertson WR.
    Clin Endocrinol (Oxf); 1993 Feb 15; 38(2):209-17. PubMed ID: 8435902
    [Abstract] [Full Text] [Related]

  • 11. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R, Alfthan H, Haukkamaa M, Heikinheimo O, Luukkainen T, Lähteenmäki P.
    Fertil Steril; 1990 Apr 15; 53(4):747-50. PubMed ID: 2108063
    [Abstract] [Full Text] [Related]

  • 12. Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme.
    Yamashita T, Ishimaru T, Fujishita A, Kawano M, Yamabe T.
    Hum Reprod; 1996 Aug 15; 11(8):1615-9. PubMed ID: 8921103
    [Abstract] [Full Text] [Related]

  • 13. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
    Derksen L, Tournaye H, Stoop D, Van Vaerenbergh I, Bourgain C, Polyzos NP, Haentjens P, Blockeel C.
    Reprod Biomed Online; 2014 Mar 15; 28(3):359-68. PubMed ID: 24456700
    [Abstract] [Full Text] [Related]

  • 14. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
    Hoffman DI, Lobo RA, Campeau JD, Tsai HM, Holmberg EA, Ono T, Frederick JJ, Platt LD, diZerega GS.
    J Clin Endocrinol Metab; 1985 May 15; 60(5):922-7. PubMed ID: 3920235
    [Abstract] [Full Text] [Related]

  • 15. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome.
    Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, de Fatis CT, Pocognoli P.
    J Clin Endocrinol Metab; 1999 Aug 15; 84(8):2659-63. PubMed ID: 10443656
    [Abstract] [Full Text] [Related]

  • 16. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI, Winter JS, Faiman C.
    Am J Obstet Gynecol; 1977 Nov 01; 129(5):557-64. PubMed ID: 910845
    [Abstract] [Full Text] [Related]

  • 17. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.
    Schipper I, Hop WC, Fauser BC.
    J Clin Endocrinol Metab; 1998 Apr 01; 83(4):1292-8. PubMed ID: 9543158
    [Abstract] [Full Text] [Related]

  • 18. [Ovarian stimulation: a new approach based on recent physiological and clinical data. Future perspectives].
    Lunenfeld B.
    Contracept Fertil Sex; 1993 Apr 01; 21(4 Suppl):1-7. PubMed ID: 7951638
    [Abstract] [Full Text] [Related]

  • 19. The synergistic effects of clomiphene citrate and human menopausal gonadotrophin in the folliculogenesis of stimulated cycles as assessed by the gonadotrophin-releasing hormone antagonist Nal-Glu.
    Cassidenti DL, Paulson RJ, Lobo RA, Sauer MV.
    Hum Reprod; 1992 Mar 01; 7(3):344-8. PubMed ID: 1587939
    [Abstract] [Full Text] [Related]

  • 20. Results of planned in-vitro fertilization programming through the pre-administration of the oestrogen-progesterone combined pill.
    Cohen J, Debache C, Solal P, Serkine AM, Achard B, Boujenah A, Pez JP, Paris X, Robert J, Loffredo V.
    Hum Reprod; 1987 Jan 01; 2(1):7-9. PubMed ID: 3106405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.